GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

116 hedge funds and large institutions have $66.6M invested in Sanofi Contingent Value Rights in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 21 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more funds holding in top 10

Funds holding in top 10: →

less capital invested

Capital invested by funds: $ → $

33% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 21

Holders
116
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$7.41M
2
+$693K
3
+$605K
4
PWAM
Park West Asset Management
California
+$428K
5
CPA
Columbia Pacific Advisors
Washington
+$166K

Top Sellers

1
-$12.9M
2
-$4.09M
3
-$1.24M
4
PC
Pomelo Capital
New York
-$542K
5
CCA
Catalyst Capital Advisors
New York
-$203K
Name Holding Trade Value Shares
Change 		Change in
Stake
76
$1K
77
$1K
78
$1K
79
$1K
80
$964
81
$718
82
$558
83
$421
84
$10
85
$7
86
–
87
–
88
–
89
–
90
–
91
–
92
–
93
–
94
–
1 2 3
4